AstraZeneca, Incyte in Lung Cancer Clinical Trial Pact
By

By
AstraZeneca and MedImmune, its global biologics research and development arm, have expanded their immuno-oncology clinical collaboration with Incyte, a Wilmington, Delaware-based biopharmaceutical company. Under the agreement, the companies will evaluate…

Daiichi Sankyo, Glycotope in ADC Pact
By

By
Daiichi Sankyo and Glycotope, a Berlin, Germany-headquartered biotechnology company, have signed an option agreement for future strategic collaboration and licensing to develop an antibody drug conjugate (ADC) by combining Daiichi…

BI Expands Immuno-Oncology Pact
By

By
Boehringer Ingelheim (BI) and Sarah Cannon Research Institute, the research arm of Nashville, Tennessee-based Sarah Cannon, a global cancer institute of the Hospital Corporation of America, have expanded their immuno-oncology…

FDA Addresses Packaging and Storage as New Strategies for Opioid Crisis
By

By
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has outlined the use of packaging and storage of opioids as new strategies for how the FDA plans to reduce the…

AMRI Appoints General Counsel and Head of Business Development
By

By
AMRI, a contract research, development, and manufacturing organization, has appointed Paul Feuerman as senior vice president, general counsel, and head of business development. Feuerman will be responsible for leading all…

AbbVie Opens Biomanufacturing Plant in Singapore
By

By
AbbVie has opened a new biologics manufacturing facility in Tuas Biomedical Park, Singapore as part of a previously announced $320-million expansion for both small molecule and biologics drug-substance manufacturing. The…

Regeneron Plans Additional $100-Million Investment in Biomanufacturing Facility in Ireland
By

By
Regeneron Pharmaceuticals, a Tarrytown, New York-based biopharmaceutical company, is investing an additional $100 million to expand its industrial operations and product supply (IOPS) bioprocessing site in Limerick, Ireland to bring…

Dr. Reddy’s Recalls More than 560,000 Bottles of Famotidine Tablets
By

By
Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered pharmaceutical company, has issued a voluntary Class III recall for 569,376 bottles of famotidine tablets (over-the-counter, 10-mg, packaged in a 30-count bottle) in the…

AMRI Launches Standalone Analytic Testing Services
By

By
AMRI, a contract research, development, and manufacturing organization, has launched impurity analytical testing as a stand-alone service. AMRI’s service is designed to help customers determine and quantify the impact of…

Sterling Pharma Invests in Milling, Micronization Capabilities
By

By
Sterling Pharma Solutions, a Dudley, England-headquartered contract development and manufacturing organization, is investing £6 million ($7.9 million) into a new facility at its UK site to expand its milling, micronization,…